Florence Ozor, FCCPC, and the N260m Range Rover: Why Coscharis Motors Must Be Held Accountable -By Jeff Okoroafor
Opinion Nigeria
Last updated: May 18, 2026
Justice Emeka Nwite of the Federal High Court in Abuja has issued a significant ruling that serves as a strong judicial warning. The court has ordered the Federal Competition and Consumer Protection Commission (FCCPC) to investigate and take action regarding alleged unfair business practices and price gouging by multinational pharmaceutical companies. This decision stems from a petition highlighting concerns over exploitative pricing of essential medicines.
- The ruling mandates the FCCPC to conduct a comprehensive investigation into the pricing strategies of these foreign drug manufacturers operating in Nigeria. Specific attention is to be paid to whether these companies are engaging in anti-competitive behavior or exploiting consumers through inflated prices. The court's directive emphasizes the need to protect Nigerian consumers from economic harm and ensure fair market practices within the pharmaceutical sector. This judicial intervention aims to address a perceived imbalance where essential medicines may be priced beyond the reach of ordinary citizens due to the actions of these multinational corporations. The judgment underscores the FCCPC's authority to regulate market activities and protect consumer welfare in the face of potential corporate malfeasance.
